Understanding Episodic Ataxias: EA-1 vs. EA-2 Clinical Comparison

Episodic Ataxias (EA) are autosomal dominant channelopathies characterized by recurrent spells of incoordination, dizziness, and imbalance. The two most recognized subtypes are EA-1 and EA-2:

Episodic Ataxia Type 1 (EA-1)

• Gene: KCNA1 (Voltage-gated potassium channel).

• Duration: Very short (seconds to minutes).

• Triggers: Sudden movement, startle, or sudden exercise.

• Interictal Finding: Myokymia (continuous fine muscle twitching around eyes/hands).

• Response: Carbonic anhydrase inhibitors (Acetazolamide).

Episodic Ataxia Type 2 (EA-2)

• Gene: CACNA1A (Calcium channel subunit).

• Duration: Longer duration (hours to days).

• Triggers: Stress, exertion, caffeine, alcohol.

• Interictal Finding: Interictal nystagmus (often downbeating nystagmus) and progressive cerebellar signs.

• Response: Dramatic response to Acetazolamide.

The Genetics Behind Paroxysmal Dyskinesia: PRRT2, PNKD, and GLUT1 Explained

Recent advances in neurogenetics have provided significant insight into the underlying mechanisms of episodic dyskinesias.

• PRRT2 (Proline-Rich Transmembrane Protein 2): Mutated in most primary PKD cases. PRRT2 interacts with SNAP-25 at the presynaptic membrane, playing a key role in neurotransmitter release. Mutations disrupt basal ganglia circuit signaling.

• PNKD (MR-1 Gene): Mutated in classic PNKD. The gene product shows homology to enzymes involved in the detoxification of methylglyoxal—a compound naturally present in coffee and alcohol, explaining why these beverages trigger attacks.

• SLC2A1 (GLUT1 Transporter): Mutated in PED. Impaired glucose transport across the blood-brain barrier leads to an energy deficit in the basal ganglia during sustained physical activity.